Cookie preferences
Quote 
Filter By
Filter By
Category: Reagents
Filter By
Reference: R1005-.1
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: R1005-1
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: R1005-5
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: R1006-.1
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing
Reference: 21576-10
€0.00
(tax incl.)
A bicyclic monoterpene with diverse biological activities; reduces the growth of a panel of seven Gram-positive bacteria, seven Gram-negative bacteria, and eight yeast strains (MICs = 0.75-1.29, 1.05-1.59, and...
Reference: R1006-1
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing
Reference: 21576-50
€0.00
(tax incl.)
A bicyclic monoterpene with diverse biological activities; reduces the growth of a panel of seven Gram-positive bacteria, seven Gram-negative bacteria, and eight yeast strains (MICs = 0.75-1.29, 1.05-1.59, and...
Reference: R1006-5
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing
Reference: 21719-1
€0.00
(tax incl.)
A monocyclic monoterpene with diverse biological activities; inhibits the growth of bacteria including S. aureus, B. cereus, E. faecalis, E. coli, P. aeruginosa, K. pneumoniae, M. catarrhalis, and C. neoformans (MICs...
Reference: R1007-.1
€0.00
(tax incl.)
New modification with better performance --- direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control to study transfection and expression in mammalian cells.
Reference: 21719-5
€0.00
(tax incl.)
A monocyclic monoterpene with diverse biological activities; inhibits the growth of bacteria including S. aureus, B. cereus, E. faecalis, E. coli, P. aeruginosa, K. pneumoniae, M. catarrhalis, and C. neoformans (MICs...
Reference: R1007-1
€0.00
(tax incl.)
New modification with better performance --- direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control to study transfection and expression in mammalian cells.
Reference: 22184-1
€0.00
(tax incl.)
A monoterpene with diverse biological activities; reduces compound action potential (CAP) peak amplitude in isolated frog sciatic nerves (IC50 = 0.51 mM); inhibits the radial growth of M. gypsum, T. vercossum, and C....
Reference: R1007-5
€0.00
(tax incl.)
New modification with better performance --- direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control to study transfection and expression in mammalian cells.
Reference: 22184-10
€0.00
(tax incl.)
A monoterpene with diverse biological activities; reduces compound action potential (CAP) peak amplitude in isolated frog sciatic nerves (IC50 = 0.51 mM); inhibits the radial growth of M. gypsum, T. vercossum, and C....
Reference: R1008-.1
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy3 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: 22184-5
€0.00
(tax incl.)
A monoterpene with diverse biological activities; reduces compound action potential (CAP) peak amplitude in isolated frog sciatic nerves (IC50 = 0.51 mM); inhibits the radial growth of M. gypsum, T. vercossum, and C....
Reference: R1008-1
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy3 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: 23159-100
€0.00
(tax incl.)
A monoterpene with diverse biological activities; inhibits the growth of S. typhimurium, E. coli, L. monocytogenes, S. epidermidis, and S. aureus (MICs = 0.266-0.608% v/v); decreases the invasive activity of HT-1080...
Reference: R1008-5
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy3 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: 23161-100
€0.00
(tax incl.)
A monoterpene with diverse biological activities; antibacterial activity against S. aureus, E. faecium, E. coli, and M. smegmatis (MICs = 0.78, 12.5, 0.78, and 1.56 μl/ml, respectively, in an agar diffusion assay) and...
Reference: R1009-.1
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy5 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: 23161-25
€0.00
(tax incl.)
A monoterpene with diverse biological activities; antibacterial activity against S. aureus, E. faecium, E. coli, and M. smegmatis (MICs = 0.78, 12.5, 0.78, and 1.56 μl/ml, respectively, in an agar diffusion assay) and...
Reference: R1009-1
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy5 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: 23161-250
€0.00
(tax incl.)
A monoterpene with diverse biological activities; antibacterial activity against S. aureus, E. faecium, E. coli, and M. smegmatis (MICs = 0.78, 12.5, 0.78, and 1.56 μl/ml, respectively, in an agar diffusion assay) and...
Reference: R1009-5
€0.00
(tax incl.)
5-moUTP-modified mRNA with better performance, Cy5 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.
Reference: 23161-50
€0.00
(tax incl.)
A monoterpene with diverse biological activities; antibacterial activity against S. aureus, E. faecium, E. coli, and M. smegmatis (MICs = 0.78, 12.5, 0.78, and 1.56 μl/ml, respectively, in an agar diffusion assay) and...
Reference: R1010-.1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: 23722-100
€0.00
(tax incl.)
A monoterpene with diverse biological activities; scavenges DPPH and ABTS+ free radicals (IC50s = 2.8 and 30 mM, respectively); reduces APPH-induced hemolysis in isolated human erythrocytes; reduces the growth of T....
Reference: R1010-1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: 23722-250
€0.00
(tax incl.)
A monoterpene with diverse biological activities; scavenges DPPH and ABTS+ free radicals (IC50s = 2.8 and 30 mM, respectively); reduces APPH-induced hemolysis in isolated human erythrocytes; reduces the growth of T....
Reference: R1010-5
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: 23722-500
€0.00
(tax incl.)
A monoterpene with diverse biological activities; scavenges DPPH and ABTS+ free radicals (IC50s = 2.8 and 30 mM, respectively); reduces APPH-induced hemolysis in isolated human erythrocytes; reduces the growth of T....
Reference: R1011-.1
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: AG-CN2-0001-M001
€0.00
(tax incl.)
Non-peptidic anti-diabetic agent. Receptor-selective glucagon antagonist. Free radical species (·OH, R·) and singlet oxygen (1O2) scavenger. Mycotoxin. Cytotoxic. Antioxidant. Inhibitor of botulinum neurotoxin...
Reference: R1011-1
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: AG-CN2-0011-M001
€0.00
(tax incl.)
Prenylated 4-hydroxycoumarin. Anti-tumor compound. Cytotoxic. Stimulator of tubulin polymerization in vitro. Inhibitor of colchicine binding to tubulin. Antitubercular antibiotic with potent antibacterial activity....
Reference: R1011-5
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Reference: AG-CN2-0011-M005
€0.00
(tax incl.)
Prenylated 4-hydroxycoumarin. Anti-tumor compound. Cytotoxic. Stimulator of tubulin polymerization in vitro. Inhibitor of colchicine binding to tubulin. Antitubercular antibiotic with potent antibacterial activity....
Reference: R1012-.1
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: AG-CN2-0011-M010
€0.00
(tax incl.)
Prenylated 4-hydroxycoumarin. Anti-tumor compound. Cytotoxic. Stimulator of tubulin polymerization in vitro. Inhibitor of colchicine binding to tubulin. Antitubercular antibiotic with potent antibacterial activity....
Reference: R1012-1
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: AG-CN2-0018-M005
€0.00
(tax incl.)
Protein transport from ER to Golgi inhibitor. ADP-ribosylation factor (Arf) inhibitor. Cytotoxic. Antibiotic. Antiviral. Apoptosis inducer. Antitumor compound. Intracellular collagen degradation inhibitor. Reviews.
Reference: R1012-5
€0.00
(tax incl.)
Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
Reference: AG-CN2-0018-M010
€0.00
(tax incl.)
Protein transport from ER to Golgi inhibitor. ADP-ribosylation factor (Arf) inhibitor. Cytotoxic. Antibiotic. Antiviral. Apoptosis inducer. Antitumor compound. Intracellular collagen degradation inhibitor. Reviews.
Reference: R1013-.1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0018-M025
€0.00
(tax incl.)
Protein transport from ER to Golgi inhibitor. ADP-ribosylation factor (Arf) inhibitor. Cytotoxic. Antibiotic. Antiviral. Apoptosis inducer. Antitumor compound. Intracellular collagen degradation inhibitor. Reviews.
Reference: R1013-1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0019-C100
€0.00
(tax incl.)
Antibiotic. PKC, PKA and PKG inhibitor. Shows neurotropic activity by inducing neurite outgrowth. Highly potent cell permeable CaM kinase and phosphorylase inhibitor. Tyrosine protein kinase inhibitor of the TRK...
Reference: R1013-5
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0019-M001
€0.00
(tax incl.)
Antibiotic. PKC, PKA and PKG inhibitor. Shows neurotropic activity by inducing neurite outgrowth. Highly potent cell permeable CaM kinase and phosphorylase inhibitor. Tyrosine protein kinase inhibitor of the TRK...
Reference: R1015-.1
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing.
Reference: AG-CN2-0020-M005
€0.00
(tax incl.)
Antibiotic. High affinity ionophore for monovalent cations such as H+, K+, Na+, Pb2+. Shows antibacterial (Gram-positive), antifungal, antitumor and antiviral activity. Disrupts membrane potential of mitochondria....
Reference: R1015-1
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing.
Reference: AG-CN2-0020-M025
€0.00
(tax incl.)
Antibiotic. High affinity ionophore for monovalent cations such as H+, K+, Na+, Pb2+. Shows antibacterial (Gram-positive), antifungal, antitumor and antiviral activity. Disrupts membrane potential of mitochondria....
Reference: R1015-5
€0.00
(tax incl.)
Used with guideRNA for site-specific DNA cleavage in genome editing.
Reference: AG-CN2-0021-M001
€0.00
(tax incl.)
Antibiotic. Protein tyrosine kinase inhibitor. Has antifungal, antimalarial, antiangiogenic (in vivo), anti-inflammatory and antiviral activity. Cyclooxygenase-2 (COX-2) expression inhibitor without affecting COX-1...
Reference: R1016-.1
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP，providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0021-M005
€0.00
(tax incl.)
Antibiotic. Protein tyrosine kinase inhibitor. Has antifungal, antimalarial, antiangiogenic (in vivo), anti-inflammatory and antiviral activity. Cyclooxygenase-2 (COX-2) expression inhibitor without affecting COX-1...
Reference: R1016-1
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP，providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0022-C100
€0.00
(tax incl.)
Antibiotic. Antifungal and anti-yeast activity. Inhibits platelet aggregation induced by collagen or ADP. Has no effect on thrombin-induced platelet aggregation. Potent, cell permeable, reversible, ATP-competitive and...
Reference: R1016-5
€0.00
(tax incl.)
EGFP mRNA with Cap 1 structure, modified by 5-moUTP，providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0022-C500
€0.00
(tax incl.)
Antibiotic. Antifungal and anti-yeast activity. Inhibits platelet aggregation induced by collagen or ADP. Has no effect on thrombin-induced platelet aggregation. Potent, cell permeable, reversible, ATP-competitive and...
Reference: R1017-.1
€0.00
(tax incl.)
mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0022-M001
€0.00
(tax incl.)
Antibiotic. Antifungal and anti-yeast activity. Inhibits platelet aggregation induced by collagen or ADP. Has no effect on thrombin-induced platelet aggregation. Potent, cell permeable, reversible, ATP-competitive and...
Reference: R1017-1
€0.00
(tax incl.)
mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0022-M005
€0.00
(tax incl.)
Antibiotic. Antifungal and anti-yeast activity. Inhibits platelet aggregation induced by collagen or ADP. Has no effect on thrombin-induced platelet aggregation. Potent, cell permeable, reversible, ATP-competitive and...
Reference: R1017-5
€0.00
(tax incl.)
mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0023-M001
€0.00
(tax incl.)
Antibiotic. Potent anti-neutrophil agent with cardioprotective effects. mTOR, DNA-PK, phosphatidylinositol 4-kinases, myosin light chain kinase (MLCK) and mitogen-activated protein kinase (MAPK) inhibitor at high...
Reference: R1018-.1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
Reference: AG-CN2-0023-M005
€0.00
(tax incl.)
Antibiotic. Potent anti-neutrophil agent with cardioprotective effects. mTOR, DNA-PK, phosphatidylinositol 4-kinases, myosin light chain kinase (MLCK) and mitogen-activated protein kinase (MAPK) inhibitor at high...
Reference: R1018-1
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
Reference: AG-CN2-0023-M025
€0.00
(tax incl.)
Antibiotic. Potent anti-neutrophil agent with cardioprotective effects. mTOR, DNA-PK, phosphatidylinositol 4-kinases, myosin light chain kinase (MLCK) and mitogen-activated protein kinase (MAPK) inhibitor at high...
Reference: R1018-5
€0.00
(tax incl.)
Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
Reference: AG-CN2-0025-C100
€0.00
(tax incl.)
Antibiotic. Antibacterial and antifungal properties. Forms a complex with FKBP12 and inhibits the mammalian target of rapamycin (mTOR). Inhibits the response to interleukin-2 (IL-2), and thereby blocks activation of T...
Reference: R1001-.1
€0.00
(tax incl.)
Direct-detection reporter mRNA, used as control to study transfection and expression in mammalian cells.
Reference: AG-CN2-0025-M001
€0.00
(tax incl.)
Antibiotic. Antibacterial and antifungal properties. Forms a complex with FKBP12 and inhibits the mammalian target of rapamycin (mTOR). Inhibits the response to interleukin-2 (IL-2), and thereby blocks activation of T...
Reference: R1001-1
€0.00
(tax incl.)
Direct-detection reporter mRNA, used as control to study transfection and expression in mammalian cells.
Reference: AG-CN2-0025-M005
€0.00
(tax incl.)
Antibiotic. Antibacterial and antifungal properties. Forms a complex with FKBP12 and inhibits the mammalian target of rapamycin (mTOR). Inhibits the response to interleukin-2 (IL-2), and thereby blocks activation of T...
Reference: R1001-5
€0.00
(tax incl.)
Direct-detection reporter mRNA, used as control to study transfection and expression in mammalian cells.
Reference: AG-CN2-0025-M025
€0.00
(tax incl.)
Antibiotic. Antibacterial and antifungal properties. Forms a complex with FKBP12 and inhibits the mammalian target of rapamycin (mTOR). Inhibits the response to interleukin-2 (IL-2), and thereby blocks activation of T...
Reference: R1020-.1
€0.00
(tax incl.)
Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0030-M250
€0.00
(tax incl.)
Antibiotic. Cytotoxic to prokaryotic and eukaryotic cells by inhibiting the protein synthesis. Apoptosis inducer. Widely employed in the selection of eukaryotic expression vectors, in combination with either...
Reference: R1020-1
€0.00
(tax incl.)
Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0030-M500
€0.00
(tax incl.)
Antibiotic. Cytotoxic to prokaryotic and eukaryotic cells by inhibiting the protein synthesis. Apoptosis inducer. Widely employed in the selection of eukaryotic expression vectors, in combination with either...
Reference: R1020-5
€0.00
(tax incl.)
Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation.
Reference: AG-CN2-0030-G001
€0.00
(tax incl.)
Antibiotic. Cytotoxic to prokaryotic and eukaryotic cells by inhibiting the protein synthesis. Apoptosis inducer. Widely employed in the selection of eukaryotic expression vectors, in combination with either...
Reference: AG-CN2-0030-G005
€0.00
(tax incl.)
Antibiotic. Cytotoxic to prokaryotic and eukaryotic cells by inhibiting the protein synthesis. Apoptosis inducer. Widely employed in the selection of eukaryotic expression vectors, in combination with either...